# ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment

> **NCT05414552** · — · COMPLETED · sponsor: **University of Freiburg** · enrollment: 11 (actual)

## Conditions studied

- Immune Related Adverse Events
- Colitis
- Hepatitis
- Dermatitis

## Interventions

- **DRUG:** ECP

## Key facts

- **NCT ID:** NCT05414552
- **Lead sponsor:** University of Freiburg
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414552, "ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05414552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*